Cardiff Lexington Corp
CDIX- Exchange
- OTC
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- SEC CIK
- 0000811222
No open-market purchases or sales by Cardiff Lexington Corp insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Cardiff Lexington Corp insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Cardiff Lexington Corp, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Staley Louis Jack Sr. | Director | 11,668 | Sep 15, 2026 | 3 |
| Pennington Catherine B. | Director | 11,668 | Sep 15, 2026 | 3 |
| Johnson Gillard B. III | Director | 11,668 | Sep 15, 2026 | 3 |
| Cunningham Alex H. | Chief Executive Officer | 3,914,230 | Feb 2, 2026 | 2 |
| Shafer Matthew T | Chief Financial Officer | 74,168 | Jan 16, 2026 | 2 |
| Thompson Daniel | Chairman of the Board | 11,666,429 | Dec 15, 2025 | 1 |
| Choe Zia | Chief Accounting Officer | – | Feb 27, 2024 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
No insider trades match these filters.